Regional Analysis

Global Pediatric Interventional Cardiology Market: Regional Insights

Based on geography, the global pediatric interventional cardiology market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the growing incidence of congenital heart conditions and increase in focus on the development of novel pulmonary and aortic heart valves in the region. For instance, interventional cardiology is a medical field often used to diagnose and treat a range of congenital heart defects in children of all ages. According to the American Heart Association, about 9 of every 1,000 babies born in the United States have a congenital heart defect, making heart defects the most common birth defects. This in turn is expected to drive market growth.

Asia Pacific is also expected to witness significant growth in the global pediatric interventional cardiology market owing to the favorable government investments in cardiology and rapid growth of medical tourism in the region. For instance, in 2021, 5 Centers of Excellence launched in India, Malaysia, and China to train pediatric cardiac specialists to treat children the fastest. The initiative has developed strong pediatric cardiology training program and developed strong connections with community providers through years of outreach and awareness building. This in turn is expected to propel the growth of the market in the region.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa